Flagship Pioneering as of Dec. 31, 2021
Portfolio Holdings for Flagship Pioneering
Flagship Pioneering holds 13 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Moderna (MRNA) | 69.0 | $4.5B | 18M | 253.98 | |
| Sana Biotechnology (SANA) | 8.2 | $530M | 34M | 15.48 | |
| Rubius Therapeutics | 5.8 | $373M | 39M | 9.68 | |
| Omega Therapeutics (OMGA) | 4.5 | $294M | 26M | 11.33 | |
| Foghorn Therapeutics (FHTX) | 4.5 | $290M | 13M | 22.87 | |
| Evelo Biosciences | 2.2 | $140M | 23M | 6.07 | |
| Seres Therapeutics (MCRB) | 1.9 | $120M | 14M | 8.33 | |
| Denali Therapeutics (DNLI) | 1.8 | $117M | 2.6M | 44.60 | |
| Kaleido Biosciences Ord (KLDO) | 0.7 | $47M | 20M | 2.39 | |
| Codiak Biosciences | 0.4 | $29M | 2.6M | 11.14 | |
| Sigilon Therapeutics | 0.4 | $29M | 10M | 2.76 | |
| Axcella Health Inc equity | 0.4 | $26M | 13M | 2.09 | |
| Syros Pharmaceuticals | 0.1 | $9.6M | 2.9M | 3.26 |
